Accelerate your Research with AI-Powered Image Analysis

Comprehensive eBook from ZEISS.

Norwegian cancer research companies merge

The Norwegian companies Ultimovacs and Zelluna Immunotherapy plan to merge. At the same time, it is made clear that Ultimovacs' CEO is leaving the company.

Are you ready for EMC 2024?

Visit ZEISS at Europe’s largest Event dedicated to Microscopy and Imaging.

Explore the latest trends and innovations in quality assurance and manufacturing

ZEISS QUALITY INNOVATION SUMMIT in Berlin, October 22-24, 2024.

Venomaid's rapid test aims to find the right snake bite treatment

Every six seconds, someone on our planet suffers a snake bite, and each time, a race against the clock begins. What kind of snake was it, and which antivenom ca...

Viktigt steg för Neola – ska göra studie med för tidigt födda

Efter år av utvecklingsarbete av sitt lungövervakningssystem har Neola Medical fått ett glädjande besked: ett tillstånd att starta sin första kliniska studie på...

Basics of Confocal Laser Scanning Microscopy

Learn about the principle of confocal fluorescence microscopy.

Medical plastics insights at Röchling

An exclusive look behind the scenes.

ProPharma

First preterm infants study – a vital step for Neola

After years of developing an advanced lung monitoring system, Neola Medical has received some delightful news: permission to start its first clinical study on p...

How the Foreign Office will promote Swedish life science exports

The broadness and innovative strength keep Swedish life science exports strong, but the protectionist tendencies in the world are worrying, says Camilla Melland...

Career coach on salaries: “There is no right or wrong”

What is a reasonable salary for my job? It's a question we all ask ourselves. But how important is a higher salary really? Career coach Tina Persson believes th...

Sanna Wallenborg blir ny vd på Lumito

Medicinteknikbolaget Lumito har anställt Sanna Wallenborg som ny vd.

Roche breddar användningen av sitt tidigare cancerläkemedel

Roche har fått FDA-godkännande för att använda sitt läkemedel Gazyva vid behandling av vuxna med aktiv lupusnefrit – en allvarlig njurkomplikation vid SLE. Besk...

Q-linea ska spara – fackliga förhandlingar inledda

Uppsalabolaget Q-linea ska minska sina operativa kostnader med tio procent. Samtidigt omfördelas resurser från utveckling till kommersiella aktiviteter, med tonvikt på USA.

Vaccine project targeting congenital infection scrapped in late-stage trial – “Clearly disappointed”

Hope for the first vaccine against the world’s most common congenital infection has taken a serious hit

Stockholm and Uppsala jointly form a life science cluster

Stockholm and Uppsala are strengthening cooperation in medical research and biotech.

ZEISS Metrology Expert Tips

New video series provides valuable expert knowledge.

Vaccinprojekt mot medfödd infektion skrotas i sen fas – ”Klart besvikna”

Hoppet om det första vaccinet mot världens vanligaste medfödda infektion har fått sig en rejäl törn.

The business coach: “We need to learn from our mistakes”

The past year has been challenging for many biotech companies, with several comapanies facing financial stress and bankruptcy. To understand how entrepreneurs c...

Column: ”Authentic leadership and clear mandates pave the way for more female CEOs”

”I believe that the aspect of having clear mandates and titles on the one hand and women progressing into top positions must be explored further”, Helena Strigå...

Novartis storsatsar på RNA-terapier – köper miljardbolag

Novartis förvärvar amerikanska Avidity Biosciences för 12 miljarder dollar, motsvarande 113 miljarder kronor. Köpet stärker bolagets position inom sällsynta mus...

AxFlow och ABEL på Euro Mine Expo 28-30 maj

Euro Mine Expo, en internationell mässa och konferens för gruvindustrin och närliggande industrier och den arrangeras vartannat år.

In search of Marcel Proust's lost health

A great writer, but also a weak person and a hypochondriac. That has been the usual image of Marcel Proust. But the pediatrician and literary scholar Carl Lindg...